Enrichment analysis in LuminalB/HER2 + patients indicated the involvement of the PD-L1/PD-1 checkpoint and JAK-STAT signaling pathways, with the latter implicated in inducing PD-L1 expression in various cancers (Doi et al. 2017). This evidence concerns the gene ERBB2 and cancer.